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cleared by endocytosis due to an internalization signal
in the Ii chain cytoplasmic tail (Roche et al., 1993). In
addition, the transfer of new class II molecules from
endocytic organelles to the surface can be blocked by
inhibiting Ii chain cleavage with the protease inhibitor
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leupeptin (Neefjes and Ploegh, 1992; Amigorena et al.,
1995; Brachet et al., 1997).
Ii chain can be processed by lysosomal cathepsins
Summary D, L, and B (Cresswell, 1996, 1998; Nakagawa et al.,
1998). However, recent work has suggested that the
Dendritic cells (DCs) developmentally regulate their cysteine protease, cathepsin S, plays a primary role in
capacity for antigen presentation by controlling the many antigen-presenting cells (APCs) (Riese et al.,
transport and surface expression of MHC class II mol- 1996). Cathepsin S efficiently catalyzes the cleavage of
ecules. These events reflect a developmental regula- a 10 kDa Ii chain intermediate, Ii-p10, that contains the
tion of invariant (Ii) chain cleavage, most likely by the amino-terminal cytoplasmic domain and terminates in
cysteine protease cathepsin S. In immature DCs, inef- CLIP. Digestion of p10 releases Ii chain from class II
ficient Ii chain cleavage due to low cathepsin S activity and causes dissociation of the nonamer, yielding ab
leads to the transport of class II-Ii chain complexes dimers bound to CLIP (Amigorena et al., 1995; Riese
to lysosomes, while in mature DCs, elevated cathepsin et al., 1996). Cathepsin S is selectively expressed by
S activity results in efficient delivery of class II ab professional APCs and has a broad pH optimum (pH
dimers to the plasma membrane. Cathepsin S is not 5±8), suggesting it is active in endocytic compartments
controlled transcriptionally but by a novel mechanism regardless of internal pH (Kirschke and Wiederanders,
involving alterations in the expression and localization 1994; Shi et al., 1994).
of an endogenous cathepsin S inhibitor cystatin C. Dendritic cells (DCs) are the most potent of all APCs,
Thus, the ratio of cystatin C to cathepsin S in devel- capable of stimulating even immunologically naive T
oping DCs helps to determine the fate of newly synthe- cells (Cella et al., 1997a; Banchereau and Steinman,
sized MHC class II molecules. 1998). They acquire antigens in peripheral tissues and
migrate to lymphoid organs to present processed pep-
tides to T cells. Antigen capture and presentation activi-Introduction
ties are uncoupled, being exhibited at distinct stages of
terminal differentiation (Mellman et al., 1998). Early orMajor histocompatibility complex (MHC) class II mole-
immature cells, corresponding to DCs in peripheral tis-cules bind exogenously derived antigenic peptides and
sues, are highly endocytic and accumulate antigen (Sal-present them to CD41 T cells (Wolf and Ploegh, 1995;
lusto et al., 1995). However, they are ineffective at anti-Watts, 1997). Class II a and b chains are translocated
gen presentation in part because newly synthesizedinto the endoplasmic reticulum (ER), where they form
class II molecules are targeted to lysosomes and de-heterodimers and associate with a third polypeptide,
graded. Maturation, corresponding to DC migration frominvariant (Ii) chain (Cresswell, 1996).Three ab dimers and
the periphery to lymphoid organs, is accompanied by aone Ii trimer assemble into nonamers, allowing export of
reduction in endocytic activity and a dramatic alterationthe complex to the Golgi apparatus. Upon reaching the
in the transport of class II molecules. First, there is antrans±Golgi network, most of the nonamers are targeted
intermediate stage characterized by a transient appear-to the endocytic pathway due to a sorting signal in the
ance of class II in peripheral nonlysosomal vesicles. ThisIi cytoplasmic domain (Bakke and Dobberstein, 1990;
is followed by a mature stage in which class II is noPieters et al., 1993; Odorizzi et al., 1994). Following cleav-
longer found internally but is targeted to the plasmaage of the Ii chain, the nonamers dissociate, and the
membrane. Mature cells develop long eponymous den-resulting ab dimers loaded with peptides are transferred
dritic processes and acquire an exceptional capacity forto the cell surface.
presentation of antigen internalized days earlier (Cella etIi chain cleavage plays a key role in controlling class
al., 1997b; Pierre et al., 1997).II function (Chapman, 1998; Pierre and Mellman, 1998).
Peptide binding can occur only after Ii chain has been Although DC maturation is accompanied by the in-
removed, since Ii chain contains an internal domain creased expression of other surface molecules that fa-
(CLIP) that occupies the binding groove of ab dimers, cilitate T cell stimulation, the regulation of MHC class II
preventing peptide loading (Ghosh et al., 1995; Cress- transport must play the central role in developmentally
well, 1996). Expression of class II at the plasma mem- restricting antigen presentation. DCs control the trans-
brane also requires Ii chain removal. Ii-ab complexes port of MHC class II molecules by a novel but simple
that reach the surface directly from the Golgi are rapidly mechanism: the controlled cleavage of Ii chain, most
likely by cathepsin S. Interestingly, cathepsin S activity
is regulated indirectly by the endogenous cysteine pro-
tease inhibitor cystatin C.*To whom correspondence should be addressed.
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distribution of Ii-p10 and of MHC class II. For this pur-
pose, we made use of a new inhibitor of cathepsin S,
N-morpholinurea-leucine-homophenylalanine-vinylsul-
fone-phenyl (LHVS) (Riese et al., 1996; Villadangos et al.,
1997). At nanomolar concentrations, LHVS is far more
selective for cathepsin S than for other cysteine prote-
ases (65-fold . cathepsin L; 6000-fold . cathepsin B),
making it a far more specific probe than leupeptin.
Treatment of late DCs with 2±5 nM LHVS resulted
in the accumulation of p10-ab complexes. After pulse-
labeling, a 10 kDa protein, corresponding to Ii-p10, was
coprecipitated with anti-class II antibodies beginning atFigure 1. Invariant Chain Distribution in Mouse DCs
1 hr of chase until at least 18 hr (Figure 2A, right panel).Postnuclear supernatants of early (immature) and late (mature) bone
In untreated late DCs, p10-ab complexes were barelymarrow±derived DCs were fractionated using a 25% Percoll density
detectable, appearing transiently between 1 and 6 hrgradient. Membranes were pelleted from each fraction, separated
on a 15% SDS-PAGE gel, and transferred to nitrocellulose mem- (left panel).
branes. Ii chain was detected with a cytoplasmic tail specific mono- To determine whether the LHVS-mediated inhibition
clonal antibody (IN1). Ii chain isoforms p31 and p41 accumulated of Ii chain processing resulted in the relocalization of
in low density fractions (ER) of early and late DCs. However, the
MHC class II, late DCs were treated with 5 nM LHVS forproteolytic fragment Ii-p10 was only found in the heavy density
12 hr, homogenized, and then centrifuged in a Percolllysosomes of early DCs (indicated by b-hexosaminidase activity,
double arrow). Only traces of Ii-p10 were detected in the low density gradient. In control late DCs, MHC class II was restricted
fractions of the late DCs. to the low density region of the gradient, consistent with
the known localization of ab dimers on the surface of
Results these cells (Figure 2B, top panel, fractions 18±23). In the
LHVS-treated late DCs, however, accumulation of class
Ii-p10 Accumulates in the Lysosomes II molecules was detected in the heavy density regions,
of Immature DCs cosedimenting with the lysosomal marker b-hexosamin-
Treatment of cells with the general cysteine protease idase (Figure 2B, lower panel).
inhibitor leupeptin promotes the accumulation of the The MHC class II molecules that appeared in lyso-
p10-ab complexes (Neefjes and Ploegh, 1992; Amigo- somal fractions due to LHVS corresponded to newly
rena etal., 1995). In A20 B cells, this results in the redistri- synthesized molecules as opposed to class II derived
bution of class II molecules to lysosomes (Brachet et from the cell surface. This was demonstrated by blotting
al., 1997) due to the lysosomal targeting signal provided Percoll gradient fractions from late DCs treated with
by the Ii chain cytoplasmic tail (Odorizzi et al., 1994). both LHVS and cycloheximide. For convenience, gradi-
We asked whether an analogous mechanism might ex- ent fractions were combined into heavy (H), intermediate
plain the different abilities of early and late DCs to accu- (I), and low (L) density pools. As expected, little class II
mulate class II molecules in lysosomes. b chain was detected in the heavy or intermediate pools
Percoll gradient centrifugation was performed on from control cells, unlike LHVS-treated cells. Cyclohexi-
preparations of bone marrow derived early and late (ma- mide treatment completely prevented the appearance
tured in presence of LPS) DCs. Ii chain distribution was of class II in the lysosomal fractions in LHVS-treated
determined by immunoblotting using the cytoplasmic cells. Similar results were obtained when the pooled
tail±specific monoclonal antibody IN1 (Figure 1). Early gradient fractions were blotted for Ii chain (Figure 2C,
and late DCs expressed comparable amounts of the p31
bottom panel). Ii-p10 was only found in cells treated
and p41 isoforms of Ii chain, the two differing by a 10
with LHVS in the absence of cycloheximide and was
kDa insertion distal to the CLIP domain (Cresswell,
detected in only the heavy and intermediate fractions.
1996). Both isoforms were largely found in low density
Thus, LHVS only inhibited the processing and targetingfractions (containing the ER, Golgi, and plasma mem-
of newly synthesized Ii chain and class II.branes) and most likely reflected Ii chain retained in the
The fractionation results were confirmed by confocalER, as this is where much new Ii chain accumulates in
microscopy. As found previously, control mature DCsDCs and other APCs (Marks et al., 1990). Early DCs also
exhibited the majority of their class II (green) on thecontained significant amounts of Ii-p10 but in heavy
plasma membrane, with little if any class II detectabledensity lysosomal fractions. Relatively little Ii-p10 was
in lgp/lamp-positive lysosomes (red) (Figure 2D). Afterfound in late DCs and only in low density fractions. These
LHVS treatment, class II molecules were detected onresults were confirmed by confocal microscopy (data
the plasma membrane but also in lysosomes, which nownot shown) and suggested that DCs developmentally
stained yellow (Figure 2E). Treatment with both LHVSregulate Ii chain processing, which, in turn, may control
and cycloheximide prevented the relocalization of classthe distribution of MHC class II molecules.
II molecules to lysosomes (Figure 2F).
Thus, the inhibition of Ii chain processing by LHVSInhibition of Ii Chain Processing by a Cathepsin S
induced late DCs to target at least a portion of theirInhibitor Induces the Redistribution of New
newly synthesized Ii-ab complexes to lysosomes. WeMHC Class II Molecules in Late DCs
next asked if developing DCs use the same strategy toWe next asked whether artificially inhibiting Ii chain deg-
radation in late DCs could phenocopy the lysosomal control class II transport.
Ii Proteolysis Controls MHC Class II Traffic
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Figure 2. Inhibition of Ii Chain Processing
and MHC Class II Targeting by the Cathepsin
S±Specific Inhibitor LHVS
(A) Pulse-chase experiments were performed
in which late DCs were incubated with or
without 5 nM LHVS for 2 hr and pulsed with
[35S]-methionine for 20 min. After various
chase times (up to 18 hr) in presence of LHVS,
cells were lysed and Ii-ab complexes immu-
noprecipitated using the Y3P antibody. In
control DCs, Ii-p10 was barely detectable
after 1 hr of chase, while in LHVS-treated cells
Ii-p10-ab began to accumulate by 1 hr and
remained stable for up to 18 hr, confirming
the inhibition of Ii-p10 cleavage by LHVS.
(B) Postnuclear supernatants of late bone
marrow±derived DCs treated (or not) with 5
nM of LHVS were fractionated using a 25%
Percoll density gradient. Pelleted membrane
fractions were separated on a 15% SDS-
PAGE gel and transferred onto nitrocellulose
membranes. MHC class II was detected by
immunoblot using the cytoplasmic tail spe-
cific polyclonal antibody (Rivoli) that detects
the b chains of I-Ab and I-Ad (indicated by
the doublets). (Top) In untreated (control) late
DCs, MHC class II accumulated on the
plasma membrane and appeared in low den-
sity fractions (fractions 18±23) and not in the
lysosomes (3±8).
(Bottom) After treatment with LHVS for 12 hr,
a considerableamount of the class II was now
detected in high density lysosomal fractions.
The low density class II reflected ab dimers
that remained on the plasma membrane.
(C) Similar experiments were performed in
presence of LHVS or LHVS together with
cycloheximide. The resulting fractions were
pooled as heavy (H, fractions 1±7), intermedi-
ate (I, fractions 8±16), and light (L, 17±24)
membranes and then immunoblotted for
MHC class II and Ii chain. As observed in (B),
control late DCs did not accumulate MHC
class II in the lysosomes (H) in contrast to the lysosomal accumulation in LHVS-treated cells. However, DCs treated with both LHVS and
cycloheximide did not accumulate class II in the heavy density fractions. In LHVS-treated DCs, p31 and p41 were found (using IN1) in the
light fractions of the gradient (L), while Ii-p10 was mainly detected in the lysosomes (H) of LHVS-treated DCs (Ii-p10 appears as a doublet
due to the fact that the gels were loaded twice to accommodate the large sample size [only low molecular weight bands were affected]).
(D) Confocal immunofluorescence microscopy of control late DCs stained for MHC class II in green and lamp 2 in red. Class II molecules
accumulated on the plasma membrane and were absent from lysosomes (MIIC).
(E) Confocal immunofluorescence microscopy of LHVS-treated late DCs stained for MHC class II in green and lamp 2 in red. In presence of
LHVS, MHC class II accumulated in lysosomes (MIIC), which thus stained yellow. The upper panel shows a thin confocal section (0.5 mm) to
best illustrate intracellular staining while reducing plasma membrane±derived background. The lower panel is a thicker optical section
demonstrating the abundance of class II remaining on the cell surface.
(F) Confocal immunofluorescence microscopy of LHVS/cycloheximide-treated late DCs stained for MHC class II in green and lamp 2 in red.
MHC class II accumulated on the plasma membrane and was clearly absent from lysosomes (MIIC). Bar, 100 mm.
Invariant Chain Degradation Is Developmentally DCs, however, a strong Ii-p10 proteolytic activity (bot-
tom panel) was detected in the heavy density, lysosomalRegulated in DCs
To determine whether early and late DCs differed in their fractions (lanes 2 and 3). Ii-p10 was cleaved z10-fold
more efficiently in the lysosomes of late DCs than incapacity for Ii chain processing, we devised an in vitro
assay to measure the degradation of Ii-p10. As sub- those of early DCs (Figure 3C). This developmental regu-
lation of Ii-p10 degradation was not due to obvious dif-strate, 35S-labeled p10-ab complexes were prepared
from LHVS-treated, I-Ab-transfected A20 B cells (Bra- ferences in amount of membranes or lysosomes be-
tween early and late DCs; equivalent numbers of cellschet et al., 1997). The labeled complexes were incubated
with fractions from Percoll gradients of unlabeled early yielded comparable amounts of protein and b-hexos-
aminidase activity in the fractions (data not shown).or late DCs, and the ability of each fraction to degrade
the Ii-p10 was monitored by SDS-PAGE. To determine whether cathepsin S was responsible
for the developmentally regulated proteolysis, we exam-As shown in Figure 3A (top panel), in fractions pre-
pared from early DCs, no obvious degradation of Ii-p10 ined the sensitivity of the lysosomal Ii-p10 processing
activity to LHVS. Lysosomal fractions from late DCscould be detected even after 2 hr of incubation. In late
Cell
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Figure 3. Ii Chain Degradation Is Develop-
mentally Controlled in DCs
(A) An in vitro degradation assay for Ii-p10
was established. Postnuclear supernatants
of equal numbers of early and late bone mar-
row±derived DCs were fractionated using a
25% Percoll density gradient. Pelleted mem-
brane fractions were pooled pairwise and re-
suspended in degradation assay buffer (see
Experimental Procedures) and incubated with
identical amounts of immunoprecipitated
[35S]-Ii-p10-ab complexes. DC membranes
and Ii-p10-ab complexes were incubated for
2 hr at 378C prior analysis by SDS-PAGE and
quantitative autoradiography to determine
the Ii-p10 processing activity present in the
DC membranes. (Top) Early DCs did not de-
grade p10 efficiently and Ii-p10 was found in
equal amounts in all the fractions. Fraction 1
was no membrane control. (Bottom) LateDCs
degraded Ii-p10 very efficiently in the lysosomal containing fractions (2±3), while the remaining fractions did not degrade added Ii-p10.
(B) Late DC lysosomal membranes were incubated for 2 hr with Ii-p10-ab and with various amounts of the cysteine protease inhibitor LHVS
(0, 0.2, 2, 200 nM). Efficient inhibition of Ii-p10 degradation by 2 nM LHVS indicates that cathepsin S was mainly responsible for Ii-p10 cleavage
in DC lysosomes and that its activity was probably regulated during DC maturation.
(C) Quantitation of three different in vitro Ii-p10 processing experiments. Late DC lysosomes (black bars) had 10-fold higher activity than the
early DC lysosomes (gray bars).
were incubated with p10-ab complexes in various con- early and late DCs were probed by immunoblot using an
antibody to cathepsin S, similar amounts of the proteasecentration of LHVS.As shown in Figure 3B, p10 degrada-
tion was strongly (75%±80%) inhibited at 2 nM LHVS. were found in both samples. Since this result did not
reflect differences in cell protein, either the regulationLittle if any further inhibition was obtained at LHVS
concentrations up to 200 nM. At 2 nM, LHVS is highly of another as yet unknown protease was responsible
for the increase in Ii-p10 processing activity, or the activ-selective for cathepsin S, while at 200 nM cathepsin L
is also inhibited (Riese et al., 1996). Although cathepsin ity of cathepsin S was regulated indirectly. We explored
the latter possibility.L also efficiently degrades Ii chain, it is active primarily
in thymic epithelial cells rather than DCs (Nakagawa et Members of the three subgroups forming the cystatin
superfamily are all potent inhibitors of cysteine prote-al., 1998). Similarly, neither cathepsin B nor D plays an
important role in Ii chain processing (Deussing et al., ases (Barrett, 1987; Turk and Bode, 1991; Henskens et
al., 1996). Family 1 (cystatins A and B) are cytosolic,1998). Thus, it is likely that cathepsin S is responsible
for most Ii chain processing in DCs. while cystatins from family 2 (C, E, and S) and 3 (kinino-
gens) are secreted and found in most biological fluids
(Abrahamson et al., 1986). Cystatin C (g-trace, 13 kDa)Regulation of Cathepsin S and Its Endogenous
Inhibitor Cystatin C during DC Maturation is the best known of all the secreted inhibitors and is a
potent inhibitor of cathepsins S (Ki 5 1 3 10212) and LWe next asked whether the Ii-p10 processing activity in
late DCs reflected anincrease in cathepsin S expression. (BroÈ mme et al., 1991; Henskens et al., 1996; Leonardi
et al., 1996). Cystatin C is secreted by mononuclearThis proved not to be the case (Figure 4, left). When
Figure 4. Immunodetection of Cathepsin S
and Cystatin C in Early and Late DCs
(Left panel) Equivalent amounts of early and
late bone marrow±derived DCs extracts were
separated by 15% SDS-PAGE and trans-
ferred to nitrocellulose. Cathepsin S was de-
tected by immunoblot with a rabbit polyclonal
anti-human cathepsin S antibody that cross-
reacted with mouse cathepsin S. Tubulin was
detected with the rabbit anti-tubulin antibody
T13. The equivalent quantities of tubulin de-
tected indicated that equal amounts of pro-
tein were transferred, as did the equivalent levels of an unknown 40 kDa cross-reactive band. Cathepsin S levels detected in early and late
DCs were equivalent in multiple experiments.
(Right panel) The same immunoblot was used to detect the cysteine protease inhibitor cystatin C (13 kDa) as well as a 15 kDa presumptive
cystatin C isoform (arrows) using a rabbit polyclonal anti-human cystatin C that cross-reacts with mouse cystatin C. Quantitation of several
blots indicated that cystatin C was down-regulated in late DCs by z3 fold; the 15 kDa band disappeared completely. (Bottom) When equivalent
amounts of cystatin C were transferred (normalized by loading three times more late DC lysate than early DC lysate), the putative novel isoform
of cystatin C was detected in early but not late DCs.
Ii Proteolysis Controls MHC Class II Traffic
1139
Figure 5. Cystatin C Colocalizes with MHC Class II in the Lysosomes of Immature LCs
(Left) Confocal immunofluorescence microscopy of immature LCs from mouse ear epidermal sheets stained for cystatin C (top) and MHC
class II (M5114, bottom). Cystatin C was found to colocalize with class II (arrows) in lysosomes (MIIC), demonstrating that cystatin C was
selectively expressed by LCs and was apparently lysosomal. Surrounding keratinocytes were largely negative for cystatin C.
(Right) Cystatin C staining was mostly lost from LCs induced to mature by incubation of epidermal sheets in LPS for 18 hr. Maturation promoted
the down-regulation of cystatin C, while, as expected, MHC class II redistributed along the dendritic processes.
phagocytes (Warfel et al., 1987; Miyake et al., 1996) and structures in LCs appeared positive for both cystatin C
and class II (arrows). Since class II is restricted to latehas been thought to play a role in tissue remodeling.
Quantitative immunoblots revealed that both early and endosomes and lysosomes in these cells (Kleijmeer et
al., 1994; Pierre et al., 1997), it is likely that cystatin C waslate DCs expressed 13 kDa cystatin C (Figure 4, right
panel). However, in late DCs, the amount of cystatin C also in late endocytic organelles. Upon LPS-induced
maturation of LCs (right panels), there was a dramaticwas reduced by z3-fold. Furthermore, a 15 kDa cystatin
C isoform was present in early DCs and totally absent decrease in cystatin C staining concomitant with a redis-
tribution of MHC class II to the plasma membrane (Pierrefrom the late DCs. The selective loss of the 15 kDa
isoform was confirmed by normalizing the blots for the et al., 1997). These results confirm the ability of cystatin
C to reach class II±containing compartments in early13 kDa cystatin C isoform (Figure 4B, bottom). Although
not dramatic, the fact that cystatin C acts as a stoichio- LCs prior to maturation. To examine the distribution of
cystatin C at higher resolution, we next examined itsmetric inhibitor of cathepsin S means that any decrease
in the cystatin C to cathepsin S ratio may result in a localization in bone marrow±derived DCs.
In early DCs (Figure 6A, upper left panel), a significantsubstantial increase in active cathepsin S.
fraction of cystatin C was in class II±positive structures
(arrowheads; yellow). Similar results were also obtainedCystatin C Localization during DC Maturation
Since cystatin C has been characterized as a secretory when cystatin C was visualized together with Ii chain
(data not shown). Thus, in immature cells, cystatin C wasprotein, it was necessary to determine whether it did
accumulate intracellularly in immature DCs. We first ex- found largely within class II±positive lysosomes (MIIC).
In late DCs (Figure 6A, upper right), remaining intracel-amined its localization in epidermal Langerhans cells
(LCs), typical immature tissue DCs that can be induced lular cystatin C accumulated in the perinuclear cyto-
plasm, while most class II was at the surface. However,to mature in situ upon treatment with LPS.
When epidermal explants from mouse ears were the intracellular class II was no longer sequestered in
lysosomes. In early or immature DCs, there was as ex-stained for cystatin C and MHC class II, intracellular
cystatin C expression was detected but only in MHC pected good if incomplete colocalization between cys-
tatin C and lamp 2, best illustrated by individual struc-class II±positive LCs (Figure 5, left panels). Keratino-
cytes expressed little if any cystatin C. Intracellular tures at the cell periphery (arrows; Figure 6A, lower left).
Cell
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Figure 6. Cystatin C Localization in Early and
Late Bone Marrow±Derived DCs
(A) Early (immature) and late (mature) DCs
were stained for cystatin C together with
MHC class II (upper panels) or lamp 2 (lower
panels). In early cells, there was extensive
colocalization of cystatin C with both class II
and lamp 2 in the perinuclear region and in
the peripheral cytoplasm. Individual vesicles
could be easily discerned in the periphery
(arrows). However, cystatin C was absent
from a minority of class II±positive organelles
(green). In late DCs, little colocalization was
observed, with most of the class II on the cell
surface leaving cystatin C in class II±negative
structures (Bars, 100 mm). As shown in the
lower right panel, these vesicles were also
negative for lamp 2, showing that in these
cells cystatin C was no longer in the endocy-
tic pathway (blue arrows). To minimize the
clustering of organelles around the MTOC,
DCs were treated with reduced amount of
LPS (20 ng/ml) during a shorter time (12 hr).
These conditions facilitated a better detec-
tion of individual cystatin C or lamp2 con-
taining organelles.
(B) Postnuclear supernatants of equal amounts
of early and late bone marrow±derived DCs
were fractionated using a 25% Percoll density
gradient. The resulting fractions were pooled
(heavy density, fractions 1±7; low density,
fractions 17±24) and Western blotted for cys-
tatin C and cathepsin S. Cathepsin S was
found in the lysosomes of early and late DCs,
while only a cross-reactive band of z45 kDa,
probably pro-cathepsin S, was detected in
the low density fractions. No differences were
observed in the distribution of cathepsin S
during DC maturation. Cystatin C was de-
tected predominantly in the lysosomal frac-
tions but only in early DCs. Upon maturation,
the amount of cystatin C in the heavy density
fractions was dramatically reduced. Although cystatin C was detected in low density fractions in late cells, even this amount was reduced
relative to early DCs. Thus, cystatin C remaining intracellularly in DCs after maturation exhibited a marked shift in intracellular distribution,
from high density lysosomes to low density membranes.
Upon DC maturation, lamp 2±positive lysosomes clus- DC maturation changes not only the level of cystatin C
expression but also its intracellular distribution.tered in the perinuclear region but were devoid of cys-
tatin C. Instead cystatin C was in lamp 2±negative pe-
ripheral structure (arrows; Figure 6A, lower right panel;
dispersed due to low LPS treatment, see legend). These Cystatin C Overexpression Induces Class II
Accumulation in the Lysosomesstructures were positive for the Golgi-specific snail lec-
tin Helix pomatia (Krijnse-Locker et al., 1994), sug- Our results thus farare clearly consistent with the regula-
tion of cystatin C in controlling cathepsin S activity.gesting that cystatin C accumulates in the Golgi com-
plex of late DCs (data not shown). However, we have not directly demonstrated that alter-
ations in cystatin C can explain the observed differencesTo further document the change in cystatin C localiza-
tion, Percoll gradient centrifugation was performed on in Ii-p10 processing or MHC class II traffic. To obtain
such evidence, we screened various class II±expressingearly and late DCs. Western blot of pooled heavy density
(lysosomal) and low density fractions confirmed that cell lines for cystatin C expression. Cell lines that local-
ized significant amounts of MHC class II to lysosomesboth isoforms of cystatin C accumulate in lysosomes of
early but not late DCs; in contrast, the amount of cathep- (e.g., macrophages, the Pala human lymphoblast cell
line) (Pierre et al., 1996) also exhibited high amounts ofsin S in lysosomes (or low density membranes) was un-
changed (Figure 6B). Some cystatin C was detected in cystatin C in endocytic organelles (data not shown).
Those that transported little class II to the lysosomesthe low density fractions of both early and late DCs, con-
sistent with a partial localization in the Golgi complex. (e.g., A20 cells) expressed relatively low amounts of
cystatin C. To demonstrate a relationship between cys-Thus, cystatin C is at least in part an intracellular
protein that can reach the endocytic pathway, where it tatin C and class II transport, we asked whether increas-
ing cystatin C levels in A20 cells could inhibit Ii chainmust be to play a role in regulating cathepsin S activity.
Ii Proteolysis Controls MHC Class II Traffic
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Figure 7. Overexpression of Cystatin C In-
duces Ii-p10 Accumulation and Transfer of
MHC Class II to Lysosomes
(A) Mouse A20 B cells (B414) expressing I-Ab
and I-Ad were stably transfected with the
mouse cystatin C cDNA. Equivalent amounts
of late DC, mock-transfected control B cells
(control), or cystatin C±transfected B cells
(Cyst C) extracts were separated on a 15%
SDS-PAGE gel and transferred to nitrocellu-
lose membranes for immunoblot. Ii chain was
detected with the cytoplasmic tail±specific
monoclonal antibody (IN1, top) and cystatin
C with the rabbit polyclonal anti-human cys-
tatin C (bottom). Transfected cells (right) were
selected for a cystatin C overexpression esti-
mated to be 3- to 4-fold higher than the con-
trol cells. Similar amounts of the Ii chain p31
isoform were detected in all the lanes, al-
though the p41 isoform was overexpressed
in DCs relative to the B cells (ªcontrol,º ªcyst
Cº). Ii-p10 proteolytic fragment does not ac-
cumulate in the late DC or the control B cells
but is found accumulating in the cystatin
C±transfected cells (right). Up-regulation of
cystatin C in A20 B cells therefore impaired
Ii-p10 degradation, probably via cathepsin S
inhibition.
(B) Confocal immunofluorescence micros-
copy of mock-transfected (left) and cystatin
C±transfected (right) B414 cells stained for MHC class II (M5114, green) and lamp 2 (red). As found previously (Brachet et al., 1997), MHC
class II (green) did not accumulate in the lysosomes (red) of the mock-transfected B414 line (the lysosomes stained red). In the cystatin
C±transfected cell line, however, MHC class II accumulated in the lysosomes as demonstrated by the significant amount of yellow staining
in the merged images. Ii chain was also detected (with IN1, data not shown) in the lysosomes of the transfected cells.
processing and induce class II accumulation in lyso- was found not only for the transfected I-Ab class II prod-
uct but also for endogenous I-Ad and Ii chain (data notsomes.
A20 B cells expressing both I-Ab and I-Ad were shown). The ability of transfected cells to accumulate
Ii-p10 and to redistribute their class II molecules to lyso-transfected with a cDNA encoding for mouse cystatin
C (Solem et al., 1990). We selected a clone expressing somes provides direct evidence that modest variations
in cystatin C levels can exert significant effects on the3- to 4-fold more than the untransfected control cells
(Figure 7A, bottom panel), so that the difference in ex- traffic of MHC class II molecules.
pression was similar to that seen in developing DCs.
The transfectants still expressed less cystatin C than Discussion
even late DCs on a per cell basis. However, cystatin C
levels are only meaningful relative to levels of cathepsin The nature of the MHC class II±containing compart-
ments has become a problem of intense interest (Watts,S or other targets.
Next, we determined the state of Ii chain in the 1997). Depending on the cell type examined, MHC class
II can accumulate in conventional late endocytic com-transfected cells (Figure 7, top panel). Although Ii chain
(p31) levels were identical in the transfected and control partments (MIIC) (Kleijmeer et al., 1997) or in vesicles
related to but distinct from early endosomes (CIIVs)cells, the slight overexpression of cystatin C significantly
increased the accumulation of Ii-p10. Interestingly, the (Amigorena et al., 1994; Drake et al., 1997). Although
the functions of these two compartments remain un-degree of Ii-p10 accumulation was greater than in late
DCs, which expressed comparable amounts of Ii chain clear, DCs are remarkable in that at different stages of
development, they localize class II molecules first in(p31). Confocal microscopy confirmed that the cystatin
C was localized to lamp 2±positive late endosomes and MIICs (lysosomes), in CIIVs, and finally on the cell sur-
face (Pierre et al., 1997). The alteration in class II trafficlysosomes (data not shown).
Control and transfected A20 B cells were then exam- is crucial, since the DC's capacity for antigen presenta-
tion isclosely linked to these events. In early DCs, class IIined for the intracellular distribution of MHC class II
molecules. As found previously (Brachet et al., 1997), molecules targeted to lysosomes (MIIC) exhibit relatively
short half-lives (t1¤2 , 12 hr) and are poorly expressedcontrol A20 cellsexhibited themajority of their class II on
the surface, with intracellular lamp 2±positive structures at the cell surface. Thus, early DCs can accumulate but
not present antigen until induced tomature by inflamma-being generally negative for class II (Figure 7, left pan-
els). However, in the cystatin C transfectants, significant tory mediators (e.g., TNFa and LPS) and redirect class
II to the plasma membrane. Thus, it was of interest toamounts of MHC class II were found in lamp 2±positive
structures, which now stained yellow (right panels). By determine the mechanisms responsible for regulating
class II transport.using different antibodies, the lysosomal redistribution
Cell
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Regulation of MHC Class II Transport density lysosomal fractions in Percoll density gradients.
However, like other lysosomal enzymes, cathepsin Sby Ii Chain Proteolysis
would be expected to accumulate in late endosomesRecent analysis of cathepsin L±deficient mice has dem-
and lysosomes despite being distributed throughout theonstrated a critical role of cathepsin L in late stages of
endocytic pathway (Kornfeld and Mellman, 1989; Mell-Ii processing, but only in thymic epithelial cells and not
man, 1996). Interestingly, cathepsin S exhibits a broadin bone marrow-derived APCs where cathepsin S is
pH activity curve, being active even at neutral pH (Bohleythought to be primarily responsible (Riese et al., 1996;
and Seglen, 1992). Thus, the enzyme is likely to be activeCresswell, 1998; Nakagawa et al., 1998). Accordingly, it
even in early endocytic compartments, which may beseemed likely that in DCs, the cathepsin S was largely
the points of entry of newly synthesized Ii-ab complexesresponsible for Ii-p10 processing, consistent with its
coming from the Golgi. Alternatively, it is possible thatsensitivity to low concentrations of LHVS. We were
Ii chain processing and sorting occurs in late endocytictherefore surprised to find that the increase in Ii chain
compartments or that Ii chain removal is needed to re-processing activity upon maturation was not accompa-
verse an active retention of class II molecules in lyso-nied by an increase in cathepsin S. Rather, there was a
somes.decrease in an endogenous inhibitor of cathepsin S,
cystatin C. In addition, the intracellular distribution of
Biology of Cystatin Ccystatin C changed markedly, being found primarily in
The presence of the cysteine protease inhibitor cystatinendocytic organelles of immature cells and in the Golgi
C in DCs and its down-regulation during maturation pro-complex of mature cells. Since cystatin C is a stoichio-
vided an attractive solution to thedevelopmental controlmetric inhibitor of cathepsin S, the partial reduction in
of Ii degradation by cathepsin S. The fact that cystatincystatin C levels combined with its depletion from endo-
C is a secreted molecule, however, had always sug-somes and lysosomes seems sufficient to explain the
gested a role in the control of extracellular proteolyticobserved increase Ii-p10 processing activity upon DC
activities (Knoch et al., 1994; Henskens et al., 1996).maturation. This possibility received direct support from
Although the ability of cystatin C to inhibit cysteine pro-the cystatin C transfection experiments in which we
teases in general, and cathepsin S in particular, haswere able to induce Ii-p10 accumulation and lysosomal
been carefully described and quantified, this activitytransport of class II by increasing cystatin C levels in
was believed to be performed extracellularly (BroÈ mme
A20 cells by only 3- to 4-fold, very similar to the variation
et al., 1991; Leonardi et al., 1996). Indeed, cystatin C
seen in developing DCs. Although we cannot formally
forms dimers at acidic pH and therefore was thought to
exclude that cystatin C±sensitive proteases other than
be inactive in the late endocytic pathway, although di-
cathepsin S could be responsible for the regulated Ii
rect evidence was never obtained (Ekiel and Abraham-
chain degradation, cystatin C has a far greater specific-
son, 1996; Merz et al., 1997). Our transfection experi-
ity for cathepsins S and L than other known protease, ments of mouse cystatin C in A20 cells demonstrated
and cathepsin L plays little if any role in DCs (Hall et al., that cystatin C can reach endocytic compartments and
1998). inhibit cathepsin activity intracellularly, as indicated by
How might the regulation of Ii chain cleavage control the accumulation of Ii-p10 in the transfectants. In addi-
the transport of MHC class II molecules? Initial clues tion, peptides derived from cystatin C could be eluted
were suggested by experiments using the broad spec- MHC class II along with Ii-CLIP and class II peptides.
trum protease inhibitor leupeptin. Leupeptin treatment This observation confirms that significant amounts of
of B cell lines led to delayed Ii chain degradation and a cystatin C have access to the endocytic pathway of
delay or complete inhibition of surface appearance of APCs and that cystatin C itself is a target for proteolysis
class II molecules (Neefjes and Ploegh, 1992; Amigorena (Rudensky et al., 1991; Rider et al., 1996). Indeed, cys-
et al., 1995; Brachet et al., 1997). The inhibition could tatin C is known to be inactivated by proteolytic degra-
also result in the accumulation of p10-ab complexes in dation by cathepsin D and elastase (Abrahamson et al.,
lysosomes, even in cells that normally transport very 1991a, 1991b; Lenarcic et al., 1991).
little class II to late endocytic compartments. An attrac- Understanding how developing DCs control the
tive explanation can be proposed based on our current amount and localization of cystatin C must await eluci-
understanding of the class II transport pathway. MHC dation of how cystatin C reaches the endocyticpathway.
class II reaches endosomes by direct targeting from Relative to early DCs, mature DCs exhibit a limited ca-
the trans±Golgi network or by endocytosis from the cell pacity for endocytosis (Sallusto and Lanzavecchia, 1994;
surface. Ii chain must then be rapidly cleaved and disso- Cella et al., 1997b). Thus, secreted cystatin C might
ciated for class II molecules toproceed from endosomes be internalized by immature but not by mature DCs as
to the plasma membrane, since the Ii chain cytoplasmic already suggested for transfected CHO cells (Merz et
domain contains a lysosomal targeting signal, which, if al., 1997). However, our finding that LCs in situ and
not removed, targets the Ii-ab complex to lysosomes. transfected B cells in culture localize cystatin C to endo-
Inefficient Ii chain processing in endosomes, as would cytic organelles makes secretion-recapture an unlikely
occur if active cathepsin S levels were low as in imma- mechanism. Thus, it is likely that the cystatin C observed
ture DCs, would thus favor class II transport to lyso- in DCs reached the endocytic pathway directly after
somes. Enhancing active cathepsin S by decreasing exiting the Golgi. The mechanisms controlling cystatin
cystatin C would increase the efficiency of Ii chain pro- C levels and targetingas well as the siteat which cystatin
cessing, thus rescuing newly arrived class II. C interacts with cathepsin S and the possible signifi-
One potential problem with this idea is that we were cance of the apparent 15 kDa cystatin C isoform are all
questions that remain to be answered.only able to detect Ii-p10 processing activity in high
Ii Proteolysis Controls MHC Class II Traffic
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Experimental Procedures (Pharmacia, Piscataway, NJ) at 48C. Lysates were immunoprecipi-
tated overnight with the Y3P anti-class II mAb and protein A-Sepha-
rose. Sepharose pellets were washed three times in precipitationMaterials
Chemicals were purchased from Sigma (St. Louis, MO) unless stated buffer, once in PBS, and transferred to degradation assay buffer
(50 mM Na acetate [pH 5.5], 1% Triton X-100, 3 mM cysteine, 1 mMotherwise.
EDTA). Fifteen microliters of the immunoprecipitated material (p10-
Ii-ab complexes) was used as substrate and incubated for 2±4 hrCell Culture
at 378C with 30 ml of DC membranes isolated after Percoll gradientMale BDF1 mice (7±8 weeks old, I-Ab and I-Ad±positive) were pur-
centrifugation. DCs (2±3 3 107) were fractionated by Percoll gradientchased from Jackson Laboratories (Bar Harbor, Maine); bone mar-
(as described above), and after high speed centrifugation of 500 mlrow±derived DCs and epidermal explants were cultured as de-
fractions, pelleted membranes were resuspended in 15 ml of assayscribed previously (Schuler and Steinman, 1985; Larsen et al., 1990;
buffer and pooled. After incubation, sample buffer was added andInaba et al., 1992; Pierre et al., 1997). Rabbit complement and mono-
electrophoresis performed using 15% SDS-PAGE gels. Gels wereclonal antibodies TIB120, GK1.5, TIB 211, and B220 were obtained
quantified using Molecular Dynamics phosphorimager or by imagefrom Pharmingen (San Diego, CA) or as hybridomas from ATCC
digitization (Visage 2000; BioImage, Ann Arbor, MI).(Gaithersberg, MD). Recombinant murine GM-CSF was produced
as a culture supernatant from J558L cells transfected with mGM-
Pulse-Chase Radiolabeling ExperimentsCSF cDNA (a kind gift of Dr. D. Gray, London, UK). DC maturation
Late DCs (3 3 107) (18 hr treatment with LPS) were incubated inwas induced by adding 100 ng/ml LPS to the cultures for 1±2 days.
methionine-free media for 2 hr in presence of 5 nM LHVS, then were
pulse-labeled with 10 mCi/ml of [35S]-methionine Translabel (ICNGeneration of Stable A20 Cell Transfectants
Biochemicals, Costa Mesa, CA) for 20 min and chased for variousMurine A20 B cells (B414, a kind gift of Charles Janeway, Yale)
times at 378C in RPMI/10% FCS with excessof methionine, cysteine,harboring the cDNAs encoding I-Ab class II molecules (selected
and LHVS. Radiolabeled cell pellets were lysed for 10 min on ice inwith G418) were transfected with the eukaryotic expression vector
10 mM Tris 150 mM NaCl (pH 7.4) containing 1% TX-100 (Sigma),pMCFRhyg (20 mg) carrying the cDNAs coding for mouse cystatin
0.5 mM PMSF, and protease inhibitor cocktails. Lysates were pre-C (ATCC #63116) (Solem et al., 1990) and a hydromycin resistance
cleared with protein A-Sepharose (Pharmacia, Piscataway, NJ) at
gene. Electroporation was performed with a Bio-Rad gene pulser
48C. Lysates were immunoprecipitated overnight with the Y3P anti-
at 270 V and 500 mF. The pMCFR expression vector was a gift of
class II rat mAb and protein A-Sepharose.
Tom Novak (Yale) (Denzin et al., 1994). Cystatin C±transfected mu-
rine B414 cells were selected and grown in a-MEM, 7.5% FCS, 50
AcknowledgmentsmM b-mercaptoethanol, 500 mg/ml hygromycin B, and 500 mg/ml
geneticin. Transfectants were cloned by limiting dilution.
The authors gratefully acknowledge members of the Mellman-Hele-
nius laboratory and Harold Chapman and Hidde Ploegh for their
Antibodies and Immunofluorescence invaluable advice and generous gifts of reagents. We also thank
Murine I-A was detected using ªRivoli,º an affinity-purified rabbit Philippe Male for quantitative image analysis. This work was sup-
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al., 1997); H2-M was detected with ªUlm,º a rabbit antibody against Institutes of Health research grants (AI-34098, GM-33904) awarded
the cytoplasmic tail of the H2-M b chain (Pierre et al., 1997); the a (to I. M.). P. P. dedicates this article to his daughter CeÂ cile.
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body (Amigorena et al., 1994); lgp-B/lamp 2 was detected with the Received February 23, 1998; revised May 15, 1998.
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anti-human cystatin C antibody was from Upstate Biotechnology
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Isolation of six cysteine proteinase inhibitors from urine: their physi-S were kind gifts of Harold Chapman and Guo-Ping Shi (Harvard,
cal and enzyme kinetic properties and concentrations in biologicalBoston, MA). Rabbit anti-tubulin T13 was a gift of Thomas Kreis
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